EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Human Herpesvirus 8 in Solid Organ Transplant Donors and Recipients: Need for Screening? A Dutch Seroprevalence Pilot Study

Geesje Roo-Brand iD, Xuewei Zhou iD, Coretta Van Leer-Buter iD, Marjolein Knoester iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70477 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Geesje Roo-Brand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, The University of Groningen, Groningen, The Netherl…. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Herpesviridae Infections, Transplant Recipients, Tissue Donors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Herpesvirus 8 (HHV8) also called Kaposi's Sarcoma‐associated herpesvirus (KSHV) is endemic worldwide. It is particularly pathogenic in immunocompromised patients. HHV8 related disease is a rare but dreaded complication in Solid Organ Transplant (SOT) recipients. Particularly donor‐derived HHV8 infections can be life threatening and have a high mortality rate. Early recognition is crucial and therefore screening of the highest risk SOT patients could lead to better outcomes. We conducted a pilot study on the seroprevalence of HHV8 in our donor and recipient populations, to calculate the risk for HHV‐8 related infections and to evaluate our current screening strategy. A total of 144 donors and 145 recipients were tested with the Indirect fluorescence assay for HHV8 Lytic IgG antibody. Seroprevalence in donors was 2.8% and 10.3% in recipients. This gives a 2.5% chance of donor positive/recipient negative (D+R−) combination, of whom a minority will develop symptomatic disease. Based on this data screening does not seem to be warranted in our center. Further multicenter studies are necessary to gain better insight in risk for symptomatic HHV8 infection in our SOT patients. Trial Registration UMCG Research Register PaNaMa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanHerpesviridae InfectionsTransplant RecipientsTissue DonorsAntibodies, ViralOrgan TransplantationHumansPilot ProjectsSeroepidemiologic StudiesMaleMiddle AgedFemaleAdultNetherlandsAgedYoung AdultMass ScreeningImmunoglobulin GAdolescent

Stichwörter der Autor:innen

HHV8SOTdonor‐derived infectionseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, The University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Geesje Roo-Brand, Xuewei Zhou, Coretta Van Leer-Buter, Marjolein Knoester

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Roo-Brand, G., Zhou, X., Van Leer-Buter, C., & Knoester, M. (2025). Human Herpesvirus 8 in Solid Organ Transplant Donors and Recipients: Need for Screening? A Dutch Seroprevalence Pilot Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70477

Vancouver

Roo-Brand G, Zhou X, Van Leer-Buter C, Knoester M. Human Herpesvirus 8 in Solid Organ Transplant Donors and Recipients: Need for Screening? A Dutch Seroprevalence Pilot Study. Journal of Medical Virology. 2025. doi:10.1002/jmv.70477

BibTeX
@article{RooBrand2025,
  author = {Roo-Brand, Geesje and Zhou, Xuewei and Van Leer-Buter, Coretta and Knoester, Marjolein},
  title = {Human Herpesvirus 8 in Solid Organ Transplant Donors and Recipients: Need for Screening? A Dutch Seroprevalence Pilot Study},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70477}
}
Kostenlos starten →